Department of Preventive Medicine, College of Medicine, Konyang University, Daejeon 35365, Korea.
Onehealth Research Laboratory, College of Medicine, Konyang University, Daejeon 35365, Korea.
Viruses. 2022 May 17;14(5):1071. doi: 10.3390/v14051071.
Many countries have implemented public health and social measures (PHSMs) to control the spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Although the PHSMs are targeted at SARS-CoV-2 transmission control, they directly or indirectly impact the epidemiology of different respiratory viral diseases. The purpose of this study was to investigate the collateral impact of PHSMs used during the coronavirus disease 2019 (COVID-19) pandemic on the epidemiology of other respiratory viruses, including influenza, parainfluenza, respiratory syncytial virus, rhinovirus, and adenovirus infections. We conducted a systematic review of the published literature on changes in the incidence of respiratory viral diseases and detection rates of the respiratory viruses during COVID-19 pandemic, lasting from 2020-2021, published between December 2019 and March 2022 in , and databases. We identified an overall decrease of 23-94% in the incidence of respiratory viral diseases and a decrease of 0-98% in the detection of the viruses. Our study suggests that the PHSMs implemented during COVID-19 pandemic reduced the incidence of respiratory viral diseases and transmission of respiratory viruses. At the time of this study, and as governments relax PHSMs, public health authorities should prepare for a probable increase in the burden of respiratory viral diseases.
许多国家已经实施了公共卫生和社会措施(PHSMs)来控制严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)的传播。虽然 PHSMs 旨在控制 SARS-CoV-2 的传播,但它们直接或间接地影响了不同呼吸道病毒疾病的流行病学。本研究旨在调查在 2019 冠状病毒病(COVID-19)大流行期间使用的 PHSMs 对其他呼吸道病毒(包括流感、副流感、呼吸道合胞病毒、鼻病毒和腺病毒感染)的流行病学的间接影响。我们对 COVID-19 大流行期间呼吸道病毒疾病发病率和呼吸道病毒检出率变化的已发表文献进行了系统评价,检索时间为 2020 年至 2021 年,检索数据库为 和 。我们发现呼吸道病毒疾病的发病率总体下降了 23%至 94%,病毒检出率下降了 0%至 98%。我们的研究表明,COVID-19 大流行期间实施的 PHSMs 减少了呼吸道病毒疾病的发病率和呼吸道病毒的传播。在本研究进行之时,随着各国政府放宽 PHSMs,公共卫生当局应做好准备应对呼吸道病毒疾病负担可能增加的情况。